Mineralocorticoid receptor deficiency in macrophages inhibits neointimal hyperplasia and suppresses macrophage inflammation through SGK1-AP1/NF-κB pathways

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 5, 2016, Pages 874-885

  Sun, Jian Yong ^a   Li, Chao ^a   Shen, Zhu Xia ^a   Zhang, Wu Chang ^a   Ai, Tang Jun ^a   Du, Lin Juan ^a   Zhang, Yu Yao ^a   Yao, Gao Feng ^a   Liu, Yan ^a   Sun, Shuyang ^b   Naray Fejes Toth, Aniko ^c   Fejes Toth, Geza ^c   Peng, Yong ^d   Chen, Mao ^d   Liu, Xiaojing ^d   Tao, Jun ^e   Zhou, Bin ^a   Yu, Ying ^a   Guo, Feifan ^a   Du, Jie ^f   Duan, Sheng Zhong ^a   more..

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d SICHUAN UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

femoral artery; hyperplasia; macrophage; mineralocorticoid receptor; myeloid cells

Indexed keywords

BROXURIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; LIPOPOLYSACCHARIDE; MINERALOCORTICOID RECEPTOR; PROTEIN C FOS; PROTEIN C JUN; PROTEIN P50; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR AP 1; IMMEDIATE EARLY PROTEIN; PROTEIN SERINE THREONINE KINASE; SERUM-GLUCOCORTICOID REGULATED KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTICLE; BONE MARROW CELL; CELL MIGRATION; CONDITIONED MEDIUM; CONTROLLED STUDY; FEMORAL ARTERY; GENE EXPRESSION; HYPERPLASIA; INFLAMMATION; MACROPHAGE; MOLECULAR MECHANICS; MOUSE; NEOINTIMAL HYPERPLASIA; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; VASCULITIS; ANIMAL; C57BL MOUSE; CELL MOTION; CELL PROLIFERATION; COCULTURE; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETIC TRANSFECTION; GENETICS; INJURIES; KNOCKOUT MOUSE; MALE; METABOLISM; NEOINTIMA; PARACRINE SIGNALING; PATHOLOGY; PHENOTYPE; RAW 264.7 CELL LINE; RNA INTERFERENCE; SMOOTH MUSCLE CELL; TIME FACTOR; VASCULAR SMOOTH MUSCLE; VASCULAR SYSTEM INJURIES;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; FEMORAL ARTERY; GENETIC PREDISPOSITION TO DISEASE; HYPERPLASIA; IMMEDIATE-EARLY PROTEINS; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; NF-KAPPA B; PARACRINE COMMUNICATION; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; RAW 264.7 CELLS; RECEPTORS, MINERALOCORTICOID; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; VASCULAR REMODELING; VASCULAR SYSTEM INJURIES;

EID: 84960351341     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.307031     Document Type: Article

References (32)

1. Cassese S, Byrne RA, Tada T, Pinieck S, Joner M, Ibrahim T, King LA, Fusaro M, Laugwitz KL, Kastrati A, Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart 2014 100 153 159. doi: 10.1136/heartjnl-2013-304933
2. Alfonso F, Byrne RA, Rivero F, Kastrati A, Current treatment of in-stent restenosis. J Am Coll Cardiol 2014 63 2659 2673. doi: 10.1016/j.jacc.2014.02.545
3. Wakabayashi K, Suzuki H, Sato T, Iso Y, Katagiri T, Takeyama Y, Eplerenone suppresses neointimal formation after coronary stent implantation in swine. Int J Cardiol 2006 107 260 266. doi: 10.1016/j.ijcard.2005.03.078
4. Ward MR, Kanellakis P, Ramsey D, Funder J, Bobik A, Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries. Circulation 2001 104 467 472
5. Kursaklioglu H, Iyisoy A, Amasyali B, Celik T, Ozturk C, Kose S, Isik E, Spironolactone does not prevent restenosis after coronary stenting in humans. Ann Acad Med Singapore 2004 33 769 774
6. Song PS, Kim DK, Seo GW, Kim KH, Seol SH, Yang JH, Hahn JY, Choi SH, Choi JH, Gwon HC, Ahn Y, Jeong MH, Song YB, Kim DI, Other Korea Acute Myocardial Infarction Registry Investigators Spironolactone lowers the rate of repeat revascularization in acute myocardial infarction patients treated with percutaneous coronary intervention. Am Heart J 2014 168 346 353.e3. doi: 10.1016/j.ahj.2014.04.019
7. Lother A, Moser M, Bode C, Feldman RD, Hein L, Mineralocorticoids in the heart and vasculature: new insights for old hormones. Annu Rev Pharmacol Toxicol 2015 55 289 312. doi: 10.1146/annurev-pharmtox-010814-124302
8. Rickard AJ, Morgan J, Tesch G, Funder JW, Fuller PJ, Young MJ, Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 2009 54 537 543. doi: 10.1161/HYPERTENSIONAHA.109.131110
9. Usher MG, Duan SZ, Ivaschenko CY, Frieler RA, Berger S, Schütz G, Lumeng CN, Mortensen RM, Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest 2010 120 3350 3364. doi: 10.1172/JCI41080
10. Bienvenu LA, Morgan J, Rickard AJ, Tesch GH, Cranston GA, Fletcher EK, Delbridge LM, Young MJ, Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis. Endocrinology 2012 153 3416 3425. doi: 10.1210/en.2011-2098
11. Li C, Zhang YY, Frieler RA, Zheng XJ, Zhang WC, Sun XN, Yang QZ, Ma SM, Huang B, Berger S, Wang W, Wu Y, Yu Y, Duan SZ, Mortensen RM, Myeloid mineralocorticoid receptor deficiency inhibits aortic constriction-induced cardiac hypertrophy in mice. PLoS One 2014 9 e110950. doi: 10.1371/journal.pone.0110950
12. Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, Heywood EB, Jones KL, Kawamori R, Cassis LA, Tschöp MH, Bruemmer D, Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 2007 117 2877 2888. doi: 10.1172/JCI31986
13. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M, MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006 116 1494 1505. doi: 10.1172/JCI26498
14. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW Jr, CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006 116 115 124. doi: 10.1172/JCI24335
15. Jenkins SJ, Ruckerl D, Cook PC, Jones LH, Finkelman FD, van Rooijen N, MacDonald AS, Allen JE, Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 2011 332 1284 1288. doi: 10.1126/science.1204351
16. Stanley ER, Chitu V, CSF-1 receptor signaling in myeloid cells. Cold Spring Harb Perspect Biol 2014 6. doi: 10.1101/cshperspect.a021857
17. Chaabane C, Otsuka F, Virmani R, Bochaton-Piallat ML, Biological responses in stented arteries. Cardiovasc Res 2013 99 353 363. doi: 10.1093/cvr/cvt115
18. McKenna NJ, O'Malley BW, SnapShot: Nuclear receptors II. Cell 2010 142 986.e1. doi: 10.1016/j.cell.2010.08.041
19. Cheng J, Wang Y, Ma Y, Chan BT, Yang M, Liang A, Zhang L, Li H, Du J, The mechanical stress-Activated serum-, glucocorticoid-regulated kinase 1 contributes to neointima formation in vein grafts. Circ Res 2010 107 1265 1274. doi: 10.1161/CIRCRESAHA.110.222588
20. Borst O, Schaub M, Walker B, Pivotal role of serum-And glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis. Arterioscler Thromb Vasc Biol 2015 35 547 557. doi: 10.1161/ATVBAHA.114.304454
21. Ferrario CM, Schiffrin EL, Role of mineralocorticoid receptor antagonists in cardiovascular disease. Circ Res 2015 116 206 213. doi: 10.1161/CIRCRESAHA.116.302706
22. Yancy CW, Jessup M, Bozkurt B, 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013 128 1810 1852. doi: 10.1161/CIR.0b013e31829e8807
23. Aouadi M, Tesz GJ, Nicoloro SM, Wang M, Chouinard M, Soto E, Ostroff GR, Czech MP, Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 2009 458 1180 1184. doi: 10.1038/nature07774
24. Kelly C, Jefferies C, Cryan SA, Targeted liposomal drug delivery to monocytes and macrophages. J Drug Deliv 2011 2011 727241. doi: 10.1155/2011/727241
25. Wynn TA, Chawla A, Pollard JW, Macrophage biology in development, homeostasis and disease. Nature 2013 496 445 455. doi: 10.1038/nature12034
26. Robbins CS, Hilgendorf I, Weber GF, Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 2013 19 1166 1172. doi: 10.1038/nm.3258
27. Amano SU, Cohen JL, Vangala P, Tencerova M, Nicoloro SM, Yawe JC, Shen Y, Czech MP, Aouadi M, Local proliferation of macrophages contributes to obesity-Associated adipose tissue inflammation. Cell Metab 2014 19 162 171. doi: 10.1016/j.cmet.2013.11.017
28. McGraw AP, Bagley J, Chen WS, Galayda C, Nickerson H, Armani A, Caprio M, Carmeliet P, Jaffe IZ, Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism. J Am Heart Assoc 2013 2 e000018. doi: 10.1161/JAHA.112.000018
29. Fiebeler A, Schmidt F, Müller DN, Park JK, Dechend R, Bieringer M, Shagdarsuren E, Breu V, Haller H, Luft FC, Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury. Hypertension 2001 37 2 pt 2 787 793
30. Sanz-Rosa D, Cediel E, de las Heras N, Miana M, Balfagón G, Lahera V, Cachofeiro V, Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: role of the NFkappaB/IkappaB system. J Hypertens 2005 23 1167 1172
31. Leroy V, De Seigneux S, Agassiz V, Hasler U, Rafestin-Oblin ME, Vinciguerra M, Martin PY, Féraille E, Aldosterone activates NF-kappaB in the collecting duct. J Am Soc Nephrol 2009 20 131 144. doi: 10.1681/ASN.2008020232
32. Terada Y, Kuwana H, Kobayashi T, Okado T, Suzuki N, Yoshimoto T, Hirata Y, Sasaki S, Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium. J Am Soc Nephrol 2008 19 298 309. doi: 10.1681/ASN.2007050531